The extracellular signal-regulated kinase is an important protein kinase for cortical plasticity. Long-term potentiation in the anterior cingulate cortex is believed to play important roles in chronic pain, fear, and anxiety. Previous studies of extracellular signal-regulated kinase are mainly focused on postsynaptic form of long-term potentiation (post-long-term potentiation). Little is known about the relationship between extracellular signal-regulated kinase and presynaptic long-term potentiation (pre-long-term potentiation) in cortical synapses. In this study, we examined whether pre-long-term potentiation in the anterior cingulate cortex requires the activation of presynaptic extracellular signal-regulated kinase. We found that p42/p44 mitogen-activated protein kinase inhibitors, PD98059 and U0126, suppressed the induction of pre-long-term potentiation. By contrast, these inhibitors did not affect the maintenance of pre-long-term potentiation. Using pharmacological inhibitors, we found that pre-long-term potentiation recorded for 1 h did not require transcriptional or translational processes. Our results strongly indicate that the activation of presynaptic extracellular signal-regulated kinase is required for the induction of pre-long-term potentiation, and this involvement may explain the contribution of extracellular signal-regulated kinase to mood disorders.
Background
Extracellular signal-regulated kinase (ERK) is one of mitogen-activated protein kinase (MAPK) family of serine/threonine protein kinases that transduce extracellular signals from cell surface receptors to the cell nucleus 1, 2 and is widely expressed in the central nervous system. ERK pathway associates with a variety of cellular activities including cell proliferation, differentiation, survival, and functional plasticity of neurons. 3 ERK pathway is also known as one of several common targets of mood stabilizers. Actually, previous studies reported that mood stabilizers, lithium, and valproate increased the activated forms of ERK1/2 and phosphorylation of ERK pathway targets in rat prefrontal cortex and hippocampus and in cultured neuronal cells. 3, 4 In anterior cingulate cortex (ACC), ERK pathway has been reported to contribute to behavioral excitement and hedonic activity. 5 Among several cortical regions, ACC is an important area for pain perception, chronic pain, and emotional disorders. [6] [7] [8] [9] [10] [11] [12] Two major forms of LTP have been reported in ACC synapses: NMDA receptor-dependent postsynaptic LTP (post-LTP) and NMDA receptorindependent presynaptic LTP (pre-LTP). 13, 14 Especially, pre-LTP is thought to be related to behavioral anxiety, and post-LTP is related to chronic pain. In previous studies, it has been reported that activation of MAPK including ERK is critical for the induction of post-LTP in the ACC. 15 There is no report of the involvement of ERK in ACC pre-LTP. However, several previous reports suggest the possible roles of ERKs in presynaptic regulation or plasticity. For example, in Aplysia, Serotonin (5-HT) gates long-term presynaptic plasticity through presynaptic regulation of MAPK/ ERK. [16] [17] [18] In hippocampus, presynaptic H-ras/ERK/ synapsin I signaling pathway adjusts the presynaptic plasticity. 19 In the present study, we performed whole-cell patchclamp recording from cingulate pyramidal neurons of adult mice and investigated the role of ERK for pre-LTP in the ACC. We showed that the induction of pre-LTP in ACC was blocked by the MAPK and ERK kinase (MEK) inhibitors. By contrast, we found that the MEK inhibitors did not affect the maintenance of ACC pre-LTP. These results suggest that the activation of MAPK including ERK is critical for the induction of pre-LTP in the ACC and indicate that ERK inhibitors may affect mood-related behaviors by inhibiting pre-LTP in the ACC.
Methods

Animals and slice preparation
C57BL/6 mice (6-14 weeks old) were anesthetized with isoflurane, and coronal brain slices (300 mm) containing the ACC were prepared using our previous methods. 13, [20] [21] [22] Slices were transferred to a submerged recovery chamber with oxygenated (95% O 2 and 5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing (in mM) 124 NaCl, 2.5 KCl, 2 CaCl 2 , 1 MgSO 4 , 25 NaHCO 3 , 1 NaH 2 PO 4 , and 10 glucose at room temperature for at least 1 h. The Animal Care and Use Committee of University of Toronto approved the mouse protocols.
Whole-cell patch-clamp recording
Experiments were performed in a recording chamber on the stage of an Axioskop 2FS microscope with infrared DIC optics for visualization of whole-cell patch-clamp recording. Neurons of the ACC in the layers II, III, and V receive afferent input from the thalamus. 23 In the present study, EPSCs were recorded from the layer II/III neurons with an Axopatch 200B amplifier (Molecular Devices, CA), and the stimulations were delivered by a bipolar tungsten stimulating electrode placed in the layer V of the ACC slices. [20] [21] [22] [23] The recording pipettes (3-5 M) were filled with solution containing (mM) 145 K-gluconate, 5 NaCl, 1 MgCl 2 , 0.2 EGTA, 10 HEPES, 2 Mg-ATP, and 0.1 Na 3 -GTP (adjusted to pH7.2 with KOH). In most of the experiments, picrotoxin (100 mM) was used to block the g-aminobutyric acid (A) (GABA A ) receptor-mediated inhibitory currents. In some experiments, LTP was induced in the absence of picrotoxin. Access resistance was 15-30 M and was monitored throughout the experiment.
Pharmacological inhibition
PD98059 and U0126 were obtained from Hello Bio (Bristol, UK). Actinomycin-D and aminomycin were obtained from Sigma-Aldrich (St. Louis, MO). These drugs were dissolved in dimethyl sulfoxide (DMSO) and diluted more than 1000-fold to give a final concentration in ACSF. The diluted DMSO in ACSF had no effect on synaptic transmission and plasticity.
Data analysis
Data were collected and analyzed using pClamp 9.2 software (Axon Instruments). Data were discarded if access resistance changed more than 15% during an experiment. The change in frequency and amplitude of postsynaptic currents following the application of drugs was analyzed using the Mini Analysis Program 6.0 (Synaptosoft, Decatur, GA). Statistical comparisons were performed using the Student's t-test, one-way analysis of variance (ANOVA), or two-way ANOVA. The Kolmogorov-Smirnov test was used to compare the cumulative distributions of the postsynaptic current parameters in the absence and presence of the test drugs. The level of significance was set at p < 0.05.
Results
MAP kinase activity is required for cingulate pre-LTP
A previous study demonstrates that LTP at synapses onto ACC pyramidal cells is postsynaptically induced and depends on the activity of ERK. 15 To investigate the effects of MAP kinase inhibition on pre-LTP in ACC synapses, we employed a stimulating protocol for inducing pre-LTP in the ACC. 13 We recorded evoked EPSCs (eEPSCs) in pyramidal neurons of layer II/III at a holding potential of À60 mV by applying local stimulation in layer V/VI in the presence of a GABA A receptor antagonist picrotoxin (100 mM) (Figure 1(b) ). After achieving a stable baseline recording in response to paired-pulse stimulation (interpulse interval of 50 ms) for at least 10 min, we then applied low-frequency paired-pulse stimulation (2 Hz for 2 min) at a holding potential of À60 mV (Figure 1(a) ). Similar to previous reports, 13, 14 we found that this stimulation robustly increased the amplitude of eEPSCs in ACC neurons and that the LTP lasted for at least 1 h (mean 164.7% AE 12.5% of baseline, n ¼ 7; Figure 1 (c) and (f)). In contrast, control neurons, which did not receive the pre-LTP induction protocol, showed no change in the amplitude of eEPSCs (mean 101.7% AE 4.8%, n ¼ 6; Figure 1(c) ). In addition, the potentiation induced by the stimulation was associated with a reduction in the paired-pulse ratio (PPR) (Figure 1(b) ). In contrast, control neurons, which did not receive the LTP induction protocol, showed no change in the PPR (109.3% AE 7.4%; Figure 1(c) ). The low-frequency stimulation statistically altered the PPR (68.6% AE 5.1% of baseline, two-way ANOVA, F 1,22 ¼ 36.33, p < 0.05; Figure 1(c) ).
Next, we tested whether pre-LTP induced by lowfrequency stimulation (2 Hz for 2 min) is prevented by bath application of a MAPK inhibitor, PD98059 (100 mM).
15,24 First, we applied PD98059 into bath solution before low-frequency stimulation. We found that PD98059 blocked pre-LTP induced by low-frequency stimulation in ACC neurons (mean 118.9% AE 10.6% of baseline, n ¼ 10, one-way ANOVA, F 2,43 ¼ 12.03, p < 0.05, PD98059 group versus pre-LTP group; Figure 1(f) ). In addition, the reduction in PPR was also blocked (Figure 1(d) ). The PD98059 application groups statistically altered the PPR compared with the pre-LTP group (92.3% AE 4.1% of baseline, two-way ANOVA, F 1,30 ¼ 27.87, p < 0.05, PD98059 group versus pre-LTP group; Figure 1(e) ).
Effect of MAP kinase on the maintenance of pre-LTP
To test whether MAPK activity is required for the maintenance of pre-LTP, we applied PD98059 (100 mM) into bath solution after the induction (Figure 2(a) ). Interestingly, we found that PD98059 did not affect the maintenance of pre-LTP in ACC neurons (156.9% AE 6.7% of baseline, n ¼ 8, one-way ANOVA, 
Effects of another MEK inhibitor
We also used another MEK inhibitor U0126 (100 mM) to investigate whether pre-LTP can be prevented. 25 Bath application of U0126 blocked the induction of pre-LTP and the reduction in PPR generated by low-frequency stimulation in ACC neurons (106.2% AE 4.5% of baseline, n ¼ 8, one-way ANOVA, F 1,32 ¼ 11.93, p < 0.05; Figure 3 (b) and (c)). In addition, the reduction in PPR was also blocked by U0126 (Figure 3(a) ). There is significant difference between U0126 application group and pre-LTP control group (89.6% AE 7.1% of baseline, twoway ANOVA, F 1,30 ¼ 17.0, p < 0.05; Figure 3(b) ).
Effects of transcriptional and translational inhibitors
Post-LTP in ACC is reported to be sensitive to the inhibition of protein synthesis. 26 Therefore, to investigate whether protein synthesis also is involved in pre-LTP, we tested the effects of transcription and translation inhibitors. First, we investigated if actinomycin-D, a transcription inhibitor, affects synaptic potentiation in ACC neurons induced by the paired training. Actinomycin-D was used at a concentration of 40 mM, a dose that reduces uridine incorpolation into RNA by 77%. 27 In ACC slices pretreated with 40 mM actinomycin-D for 30 min, pre-LTP induced by low-frequency stimulation was not affected as compared with pre-LTP group (164.9% AE 6.4% of baseline, n ¼ 11; Figures 4(a) , (b), and (e)). In addition, there was no significant difference of the PPR between actinomycin-D and pre-LTP (68.4% AE 4.0% of baseline, two-way ANOVA, F 1,32 ¼ 0.06, NS; Figure 4 (b)). We also investigated the effects of a translation inhibitor, anisomycin, on presynaptic potentiation in the ACC. Anisomycin was used at a concentration of 20 mM, which inhibited the maintenance phase of hippocampal LTP. 28, 29 In ACC slices pretreated with 20 mM anisomycin, pre-LTP was not affected as compared with control (153.4 AE 10.3% of base line, n ¼ 9; Figure 4 (c) to (e)). Also, there is no significant difference of the PPR between aminomycin and pre-LTP, similar to the results obtained in the presence of actinomycin-D (68.5% AE 4.1% of baseline, two-way ANOVA, F 1,28 ¼ 0.03, NS; Figure 4(d) ). These results suggest that protein synthesis is not required for presynaptic potentiation in the ACC neurons.
Effects of MAP kinases on baseline paired-pulse facilitation (PPF) and spontaneous EPSCs
To examine the effect of PD98059 and U0126 on PPF, a simple form of synaptic plasticity, we applied PD98059 (100 mM) or U0126 (100 mM) into bath solution. Both PD98059 and U0126 did not affect PPF (PD98059: n ¼ 5, U0126: n ¼ 5; Figure 5(a) ). These results suggest that the MEK inhibitors had no effect on basal synaptic transmissions in ACC synapses. To assess the impact of MAPK on spontaneous excitatory synaptic transmission, we applied PD98059 (100 mM) or U0126 (100 mM) into bath solution. Application of PD98059 resulted in no effect on the frequency and amplitude of spontaneous EPSCs (sEPSCs) (Figure 5(b) ). no significant difference with control (87.9 AE 10.4% and 99.6 AE 2.0% (n ¼ 6), respectively; Figure 5(g) ). These results suggest that the ERK inhibitors have no effect on the sEPSCs in ACC.
Presynaptic glutamate release is altered in ACC during training
To investigate whether the readily releasable pool of glutamate vesicles would be affected by ERK inhibitors, we applied the low-frequency stimulation which induces pre-LTP (Figure 6(a) ). This stimulation protocol, which causes a continuous decline in neurotransmitter release, resulted in a rapid and pronounced activitydependent depression. Interestingly, glutamate releases of PD98059 group (n ¼ 6) and U0126 (n ¼ 6) group significantly decreased less than control group (n ¼ 6) (oneway ANOVA, F 2,177 ¼ 12.53, p < 0.05; Figure 6 (b) and (c)). This result suggests that ERK affects glutamate release mechanism in the ACC, in addition to its contribution to the induction of pre-LTP in ACC.
Discussion
In the present study, we demonstrate that ERK activity is required for the induction of pre-LTP in the ACC. Interestingly, inhibiting ERK activity affects synaptic responses to repetitive stimulation, suggesting possible presynaptic involvement of ERK. By contrast, the maintenance of pre-LTP does not require the ERK activity. Inhibiting ERK did not affect the spontaneous glutamate releases and baseline PPF induced by paired-pulse stimulation. Together with previous report of ERK requirement for post-LTP, our results suggest that ERK play important roles in both pre-and post-LTP in ACC. Unlike post-LTP, we found that protein synthesis is not required for pre-LTP, at least for the period time we recorded (1 h). We cannot rule out the possibility that late-phase pre-LTP (more than 3 h) may be sensitive to inhibition of ERK and protein synthesis.
The molecular mechanism of pre-LTP in the ACC
The current study provides strong evidence that pre-LTP in ACC of adult mice requires ERK activity. Our recent study has reported low-frequency stimulation (2 Hz for 2 min) induced LTP presynaptically. 13 The induction of ACC pre-LTP is independent of NMDARs. Furthermore, postsynaptic G protein-coupled receptors, postsynaptic Ca 2þ influx, metabotropic glutamate receptors, GABA B Rs, and protein kinase M zeta (PKMz) that are important for the induction of post-LTP in ACC are not required for pre-LTP. 13 For pre-LTP, activation of GluK-1 containing Kainate receptors (KARs) and calcium-stimulated AC1 are necessary. 13 One key protein kinase involved in pre-LTP is cAMP-dependent protein kinase (PKA). It has been reported that PKA is required for long-lasting increases in transmitter release at many cortical synapses [30] [31] [32] [33] as well as in ACC. 13 In addition, it has been reported that presynaptic MAPK is activated by cAMP independently of PKA. 34, 35 In rat prefrontal cortex neurons, cAMP activates ERK signaling pathways to induce presynaptic potentiation. 36 Our current results provide new roles for MAPK in ACC pre-LTP. One possible downstream protein is synapsin I. Activation of ERK was reported to facilitate glutamate release from synaptosomes in rat brain by phosphorylating the synaptic vesicle membrane protein synapsin I, thereby regulating its interaction with the actin cytoskeleton, leading to the recruitment of releasable synaptic vesicles from a distal pool. 37 In the present study, PD98059 (ERK inhibitor) and U0126 (MEK inhibitor) inhibited pre-LTP in ACC, indicating that activation of MAPK/ERK may contribute to enhanced release of glutamate in ACC pre-LTP.
ERK is not required for the maintenance of pre-LTP
We previously reported that hyperpolarization-activated cyclic nucleotide-gated (HCN) channels were important for the maintenance of pre-LTP in ACC. 13 On the other hand, previous Aplysia studies have reported that maintenance of memory-related long-term facilitation of presynapses requires upregulation and prion-like activation of CPEB, a synaptic translational regulator through MAPK/ERK signaling. 16 Therefore, in the present study, we tested whether MAP/ERK signaling cascade is also related to the maintenance in addition to HCN channels and found that the maintenance of cingulate pre-LTP was not affected by both PD98059 and U0126. This suggests that the MAPK/ERK signaling cascade is not persistently activated during pre-LTP in the ACC.
Glutamate releasable vesicles are increased by ERK
Presynaptic vesicle mobilization is a complex phenomenon that is regulated by a number of protein kinases. One of most important kinase is MAPK, highly expressed at the presynaptic terminal. 38, 39 Previous studies have demonstrated that MAPK can increase releasable vesicles and induce glutamate exocytosis by phosphorylation of synapsin I which is a major substrate for MAPK and a presynaptic protein regulating the vesicle cycle and neurotransmitter release. 38, 40 Although under the inactive condition, synapsin I anchors synaptic vesicles to cytoskeletal elements, once phosphorylated by MAPK, it dissociates from synaptic vesicles and increases more releasable vesicles at presynaptic active zone for neurotransmitter release. 38, 41 In this study, we showed that ERK/MEK inhibitors did not affect baseline PPF and spontaneous EPSC in the ACC neurons under resting condition. This means that these kinase can be activated by a condition such a low-frequency stimulation and then enhance glutamate releases on presynaptic neurons.
Physiological and pathological significance
ACC is known to play an important role as the higher brain function in chronic pain, fear, and anxiety. [6] [7] [8] [9] [10] [11] [12] Previous behavioral studies show that in ACC ERK signaling pathway contributes to behavioral excitement and hedonic activity. 5 Since pre-LTP has been shown to contribute to behavioral anxiety, especially chronic painrelated anxiety, 13 the present study provides a possible explanation that ERK may contribute to mood control by triggering pre-LTP in ACC pyramidal cells. Furthermore, for pain perception and pain unpleasantness, there are strong evidence that ERK activity in the ACC are critical in addition to spinal cord dorsal horn ERK activity. 42 It has been reported that ERK signaling pathway is activated in the ACC after peripheral tissue or nerve injury. 43 Furthermore, mechanical allodynia significantly activated ERK activity at synaptic sites at two weeks after the injury, suggesting that ACC activation of ERK may contribute to both induction and expression of chronic pain. Activation of ACC ERK pathway has also been reported in animal model of visceral pain. 44 Finally, inhibiting ERK activation in ACC blocked the expression of formalin-induced conditioned place avoidance in freely moving animals. 45 Future studies are clearly needed to further determine molecular mechanism for the roles of ERK activity in pain, mood, as well as memory.
